2024
Investigating the overlapping presentation of irritable bowel syndrome and vulvodynia: a scoping review of the evidence and mechanisms
Perelmuter S, Soogoor A, Maliszewski K, Grimshaw A. Investigating the overlapping presentation of irritable bowel syndrome and vulvodynia: a scoping review of the evidence and mechanisms. Sexual Medicine Reviews 2024, 12: 559-568. PMID: 39084679, DOI: 10.1093/sxmrev/qeae053.Peer-Reviewed Original ResearchIrritable bowel syndromeDiagnostic delayPresentation of irritable bowel syndromeQuasi-experimental studyInception of databasesIncreased risk of sexual dysfunctionCross-sectional studyCase-control studyBowel syndromeRisk of sexual dysfunctionWeb of ScienceSignificant diagnostic delayImprove screeningMultifactorial medical conditionIBS diagnosisCohort studyMedical conditionsReduced qualityMast cell involvementCochrane LibraryComprehensive searchScience DirectIncreased likelihoodIncreased riskGoogle Scholar
2021
Non-steroidal treatment of cardiac sarcoidosis: A systematic review
Gallegos C, Oikonomou EK, Grimshaw A, Gulati M, Young BD, Miller EJ. Non-steroidal treatment of cardiac sarcoidosis: A systematic review. IJC Heart & Vasculature 2021, 34: 100782. PMID: 33997256, PMCID: PMC8105294, DOI: 10.1016/j.ijcha.2021.100782.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsNon-steroidal treatmentSteroid-sparing agentCardiac sarcoidosisSafety profileSystematic reviewCases of CSDisease-modifying antirheumatic agentsManagement of CSActive cardiac sarcoidosisAnti-inflammatory managementAverage corticosteroid doseHigher-line treatmentsMaintenance steroid doseFirst-line treatmentSide effect profileSteroid-sparing therapiesInception of databasesLong-term useCorticosteroid doseSteroid doseBiologic DMARDsImmunosuppressive therapyTreatment initiationEffect profileImmunosuppressive agents